Results 61 to 70 of about 36,254 (205)

Impact of rivaroxaban on point-of-care assays [PDF]

, 2017
BACKGROUND: Point-of-care testing (POCT) is regularly used to assess haemostasis in various clinical settings. The impact of rivaroxaban on those POCT is still elusive.
Hans Stricker, Mendez, Adriana, Schmid, Pirmin, Wolfgang Korte, Walter A. Wuillemin, Adriana Mendez, Michael Nagler, Studt, Jan-Dirk, Stricker, Hans, Alberio, Lorenzo, Pirmin Schmid, Dimitrios A. Tsakiris, Angelillo-Scherrer, Anne, Lorenzo Alberio, Tsakiris, Dimitrios A, Anne Angelillo-Scherrer, Lars M. Asmis, Pierre Fontana, Jan-Dirk Studt, Asmis, Lars, Asmis, Lars M, Nagler, Michael, Fontana, Pierre, Korte, Wolfgang, Wuillemin, Walter A, Wuillemin WA, Tsakiris DA, Studt JD, Korte W, Alberio, L., Nagler, M., Schmid, P., Asmis, L.M., Asmis LM, Nagler M, Schmid P, Fontana P, Korte, W., Mendez, A., Angelillo-Scherrer, A., Wuillemin, W.A., Studt, J.D., Stricker, H., Alberio L, Tsakiris, D.A., Mendez A, Angelillo-Scherrer A, Fontana, P., Stricker H   +48 more
core   +1 more source

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events

Phytotherapy Research, EarlyView.
An overview of the role of natural products (NP) in cardiovascular disease prevention, highlighting key mechanisms of action: including antiplatelet, antithrombotic, anti‐inflammatory, and antioxidant effects. Additionally, it illustrates the integration of diet–drug interactions, nutritional epigenetics, and the role of artificial intelligence in ...
Maria Nektaria Magkoulia, Despoina Pantazi   +1 more
wiley   +1 more source

Cost-effectiveness and budget impact analysis of rivaroxaban with or without aspirin compared to aspirin alone in patients with coronary and peripheral artery diseases in Iran

BMC Health Services Research
Background Low-dose aspirin and rivaroxaban are the cornerstone treatment for cardiovascular prevention in patients with peripheral artery disease (PAD) and/or stable coronary artery disease (SCAD).
Zahra Goudarzi, Zhila Najafpour, Ahmad Gholami, Khosro Keshavarz, Mohammad Mahdi Mojahedian, Mohammad Mehdi Babayi   +5 more
doaj   +1 more source

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases

Phytotherapy Research, EarlyView.
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin, Inho Cho, Xue Zhu, Ke Wang, Ling Zhu, Wenchang Wong, Michael Murray, Fanfan Zhou   +7 more
wiley   +1 more source

Whole‐Body CT Utilisation in Adult Trauma: Guideline Compliance, Incidental Findings, and the Role of Anticoagulation in Low‐Energy Falls at a Regional New Zealand Centre

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Whole‐body CT (WBCT) is central to major trauma assessment, but indiscriminate use carries a substantial radiation burden. The Central Region Trauma Network's Early Radiological Imaging in Major Trauma Guideline (CPG154), adopted at this centre, specifies criteria for WBCT and excludes low‐energy falls from standing height.
Vamsi Thammandra, Jonny Russell
wiley   +1 more source

Predictors of early initiation of rivaroxaban.

, 2022
Predictors of early initiation of rivaroxaban.
Etsuro Mori (159527), Shinichiro Uchiyama (4870921), Shinichi Yoshimura (359132), Takehiko Nagao (4870924), Teruyuki Hirano (6331382), Masahiro Yasaka (6269139), Kazuo Minematsu (666282), Akira Tempaku (12359838), Toshimitsu Hamasaki (542228), Hiroshi Yamagami (787880), Junpei Koge (10573572), Masahito Fujishige (12359835), Kazunori Toyoda (563887), Masatoshi Koga (6495125)   +13 more
core   +1 more source

Pulmonary Embolism—A Century of Progress

ANZ Journal of Surgery, EarlyView.
Reviews a century of progress in the diagnosis, prevention, and management of pulmonary embolism; from the first successful surgical embolectomy in 1924 to advanced imaging, pharmacological thromboprophylaxis, and treatment. In the 21st century, advances include catheter‐directed thrombolysis or mechanical thrombectomy under decision‐making guidance of
D. A. Watters
wiley   +1 more source

Rivaroxaban and Hemostasis in Emergency Care [PDF]

, 2020
Rivaroxaban is an oral, direct Factor Xa inhibitor, approved for the prevention and treatment of several thromboembolic disorders. Rivaroxaban does not require routine coagulation monitoring and has a short half-life. However, confirmation of rivaroxaban
Edita Rutkauskaite, Jürgen Koscielny
core  

Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non‐Anticoagulated Patients

Alimentary Pharmacology &Therapeutics, EarlyView.
Among 11,387 patients with acute gastrointestinal bleeding, overlap‐weighted analyses (n = 10,044) found no statistically significant association between direct oral anticoagulant or warfarin use and 30‐day or 1‐year mortality. Haemodynamic shock was associated with 30‐day mortality, whereas age and Internal Medicine ward admission were associated with
Esther Forkosh, David Hakimian, Harold Jacob, Ian M. Gralnek, Lior Katz, Aviv Talmon   +5 more
wiley   +1 more source

Drug-drug interactions between epidermal growth factor receptor tyrosine kinase inhibitors and rivaroxaban in vitro and in vivo.

PLoS ONE
BackgroundTyrosine kinase inhibitor (TKI) and rivaroxaban co-administration is common for patients with cancer and venous thromboembolism. However, the drug-drug interactions (DDIs) between epidermal growth factor receptor (EGFR) TKIs and rivaroxaban ...
Dongxu Wang, Shuanghu Wang, Hualan Wu, Peiwu Geng, Yang An, Xiaoyue Zhou, Minghui Du, Yuwei Li, Jia Chong, Yingying Li, Fang Wang, Zebei Lu, Yu Wang, Jiefu Yang, Chuanbao Li, Dapeng Dai, Hao Chen   +16 more
doaj   +1 more source